Literature DB >> 10567812

Relationship between brain structure sizes and performing rapid limb movements. A quantitative magnetic resonance study.

S I Bekkelund1, C Pierre-Jerome, J Winther, S I Mellgren.   

Abstract

In this study, we aimed to determine the relationship between the size of cerebral structures evaluated by quantitative magnetic resonance technique and the ability of performing rapid-velocity limb movements. Forty-seven healthy women with a mean age of 43.4 years (range 22-68) were included. Exclusion criteria were systemic diseases including alcoholism. Finger and ankle tapping were quantitatively recorded for both right and left extremities. A mean value for the right and left side was calculated. To determine atrophy, we measured the area of the corpus callosum, the cerebrum and the cerebellum on midline sagittal sections. On transverse images, the ventricle-to-brain ratio, the bifrontal ratio and the bicaudate ratio were selected as atrophy parameters. Also, the prevalence of white matter hyperintensities was assessed. Fifteen (32%) had hyperintense white matter lesions. Using simple regression analysis, the frequencies of both finger (r = 0.37, beta = -0.002, p = 0.022) and ankle (r = 0.35, beta = -0.001, p = 0.032) tapping were associated with reduced cerebellar size. No association was found for other atrophy parameters or the number of hyperintense white matter lesions. This study indicates that impaired ability to perform fast limb movements may be related to a relative cerebellar atrophy. Copyright 1999 S. Karger AG, Basel

Entities:  

Mesh:

Year:  1999        PMID: 10567812     DOI: 10.1159/000008104

Source DB:  PubMed          Journal:  Eur Neurol        ISSN: 0014-3022            Impact factor:   1.710


  1 in total

1.  Contributions of age and alcohol consumption to cerebellar integrity, gait and cognition in non-demented very old individuals.

Authors:  Olivier Piguet; Jane Cramsie; Hayley P Bennett; Jillian J Kril; Tanya C Lye; Alastair J Corbett; Michael Hayes; Helen Creasey; G Anthony Broe
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2006-08-17       Impact factor: 5.270

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.